Showing results (971-980 of 4,574) with videos related to
Sort By:
Pageof 458
Experimental Dermatology|November 9, 2005
The status quo and quo vadis of mast cellsMarcus Maurer, Martin MetzExperimental Dermatology|June 28, 2018
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosisTakashi Taniguchi, Takuya Miyagawa, Satoshi Toyama, et al.Experimental Dermatology|August 20, 2016
Does melanin matter in the dark?Przemysław M Płonka, Mauro Picardo, Andrzej T SlominskiExperimental Dermatology|August 20, 2016
Fullerene C60 with cytoprotective and cytotoxic potential: prospects as a novel treatment agent in Dermatology?Angelique Rondags, Wing Yan Yuen, Marcel F Jonkman, et al.Experimental Dermatology|August 26, 2018
FoxO1 enhances differentiation and apoptosis in human primary keratinocytesGe Shi, Pei-Yu Liao, Xiao-Lin Cai, et al.Experimental Dermatology|August 10, 2018
MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in cultureMagda Babina, Zhao Wang, Metin Artuc, et al.Experimental Dermatology|August 5, 2018
Candidate long-range regulatory sites acting on the IL17 pathway genes TRAF3IP2 and IL17RA are associated with psoriasisJoanne Nititham, Calum Fergusson, Colin Palmer, et al.Experimental Dermatology|February 19, 2010
Increased levels of serum IL-31 in chronic spontaneous urticariaUlrike Raap, Dorothea Wieczorek, Manuela Gehring, et al.Experimental Dermatology|February 19, 2010
HSP70 inducers from Chinese herbs and their effect on melanin productionYasuhiro Yamashita, Tatsuya Hoshino, Minoru Matsuda, et al.Experimental Dermatology|February 19, 2010
Smoking but not homozygosity for CYP1A2 g-163A allelic variant leads to earlier disease onset in patients with sporadic porphyria cutanea tardaAntonio Fontanellas, María Martínez-Fresno, María Concepción Garrido-Astray, et al.Pageof 458